PsychPlus

PsychPlus in Dallas, Texas, serving the North Dallas area, offers Spravato (esketamine), an FDA-approved treatment for adults with treatment-resistant depression, administered in-office under clinical supervision. Spravato acts on a different brain pathway than conventional antidepressants, offering relief for patients who have not found success with other medications.

The practice focuses on personalized, evidence-based psychiatric care with a thorough upfront evaluation to identify the most effective treatment for each patient.

Beyond Spravato, the North Dallas clinic provides psychiatry, therapy, medication management, TMS, neuropsychological testing, and an intensive outpatient program (IOP), with both in-person and virtual appointments available. Walk-ins are welcome Monday through Friday, and PsychPlus is in-network with most insurance, including Medicare and Medicaid.